Kevin Sampson

Kevin Sampson has a diverse work experience in the finance industry. Kevin began their career as a Senior Auditor and Associate at Arthur Andersen, LLP, where they worked in the High-Tech Practice and the Global Corporate Finance Division. After that, they served as the VP of Finance at Marathon Investment Partners, managing accounting operations and financial reporting. Kevin then worked as the Director of Finance at Mass Business Development Corp, responsible for portfolio management and compliance. Kevin also held the role of VP, Corporate Controller at Sentient Jet, overseeing financial operations and supporting the company's growth through acquisitions. Kevin later became VP Finance at Hocoma, Inc, where they managed financial reporting and analysis, as well as assuming PL responsibility for customer service. Kevin then transitioned to the role of Director of Accounting and Administration at SFJ Pharmaceuticals, Inc, leading financial planning and corporate development. Before joining their current company, Kevin held positions as Director of Accounting and Administration at Q-State Biosciences and Director of Accounting and Administration at Nuvelution, Inc. Currently, they are the VP Finance at the Health Data Analytics Institute, focusing on building and deploying AI-enabled predictive models for healthcare organizations.

Kevin Sampson completed their Bachelor of Science (BS) degree in Accounting, with a minor in Economics, from Babson College in the years 1989 to 1994. Kevin then pursued an MBA in Finance and Entrepreneurship from Babson F.W. Olin Graduate School of Business, completing it in the years 2002 to 2003. Additionally, Kevin obtained a certification as a Public Accountant in Massachusetts from the Commonweath of MA Division of Public Licensure in 2003. Kevin also holds a certification as a Certified Public Accountant from an institution identified as 8450, although the date of obtaining this certification is not provided.